Conventional Hospitalization versus Sequential Outpatient Parenteral Antibiotic Therapy for Staphylococcus aureus Bacteremia : Post-Hoc Analysis of a Multicenter Observational Cohort
It is not known whether sequential outpatient parenteral antimicrobial (OPAT) is as safe and effective as conventional hospitalization in patients with S. aureus bacteremia (SAB). A post-hoc analysis of the comparative effectiveness of conventional hospitalization versus sequential OPAT was performed in two prospective Spanish cohorts of patients with S. aureus bacteremia. The PROBAC cohort is a national, multicenter, prospective observational cohort of patients diagnosed in 22 Spanish hospitals between October 2016 and March 2017. The DOMUS OPAT cohort is a prospective observational cohort including patients from two university hospitals in Seville, Spain from 2012 to 2021. Multivariate regression was performed, including a propensity score (PS) for receiving OPAT, stratified analysis according to PS quartiles, and matched pair analyses based on PS. Four hundred and thirteen patients were included in the analysis: 150 in sequential OPAT and 263 in the full hospitalization therapy group. In multivariate analysis, including PS and center effect as covariates, 60-day treatment failure was lower in the OPAT group than in the full hospitalization group (p < 0.001; OR 0.275, 95%CI 0.129−0.584). In the PS-based matched analyses, sequential treatment under OPAT was not associated with higher 60-day treatment failure (p = 0.253; adjusted OR 0.660; % CI 0.324−1.345). OPAT is a safe and effective alternative to conventional in-patient therapy for completion of treatment in well-selected patients with SAB, mainly those associated with a low-risk source and without end-stage kidney disease.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Antibiotics (Basel, Switzerland) - 12(2023), 1 vom: 09. Jan. |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Bacteremia |
|---|
| Anmerkungen: |
Date Revised 08.03.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/antibiotics12010129 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM351820531 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM351820531 | ||
| 003 | DE-627 | ||
| 005 | 20231226052310.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/antibiotics12010129 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1172.xml |
| 035 | |a (DE-627)NLM351820531 | ||
| 035 | |a (NLM)36671330 | ||
| 035 | |a (PII)129 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Castillo-Fernández, Nerea |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Conventional Hospitalization versus Sequential Outpatient Parenteral Antibiotic Therapy for Staphylococcus aureus Bacteremia |b Post-Hoc Analysis of a Multicenter Observational Cohort |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 08.03.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a It is not known whether sequential outpatient parenteral antimicrobial (OPAT) is as safe and effective as conventional hospitalization in patients with S. aureus bacteremia (SAB). A post-hoc analysis of the comparative effectiveness of conventional hospitalization versus sequential OPAT was performed in two prospective Spanish cohorts of patients with S. aureus bacteremia. The PROBAC cohort is a national, multicenter, prospective observational cohort of patients diagnosed in 22 Spanish hospitals between October 2016 and March 2017. The DOMUS OPAT cohort is a prospective observational cohort including patients from two university hospitals in Seville, Spain from 2012 to 2021. Multivariate regression was performed, including a propensity score (PS) for receiving OPAT, stratified analysis according to PS quartiles, and matched pair analyses based on PS. Four hundred and thirteen patients were included in the analysis: 150 in sequential OPAT and 263 in the full hospitalization therapy group. In multivariate analysis, including PS and center effect as covariates, 60-day treatment failure was lower in the OPAT group than in the full hospitalization group (p < 0.001; OR 0.275, 95%CI 0.129−0.584). In the PS-based matched analyses, sequential treatment under OPAT was not associated with higher 60-day treatment failure (p = 0.253; adjusted OR 0.660; % CI 0.324−1.345). OPAT is a safe and effective alternative to conventional in-patient therapy for completion of treatment in well-selected patients with SAB, mainly those associated with a low-risk source and without end-stage kidney disease | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Staphylococcus aureus | |
| 650 | 4 | |a bacteremia | |
| 650 | 4 | |a outpatient parenteral antimicrobial therapy | |
| 700 | 1 | |a Pérez-Crespo, Pedro María Martínez |e verfasserin |4 aut | |
| 700 | 1 | |a Salamanca-Rivera, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Herrera-Hidalgo, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a de Alarcón, Arístides |e verfasserin |4 aut | |
| 700 | 1 | |a Navarro-Amuedo, María Dolores |e verfasserin |4 aut | |
| 700 | 1 | |a Marrodán Ciordia, Teresa |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez-Rodríguez, María Teresa |e verfasserin |4 aut | |
| 700 | 1 | |a Sevilla-Blanco, Juan |e verfasserin |4 aut | |
| 700 | 1 | |a Jover-Saenz, Alfredo |e verfasserin |4 aut | |
| 700 | 1 | |a Fernández-Suárez, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a Armiñanzas-Castillo, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Reguera-Iglesias, José María |e verfasserin |4 aut | |
| 700 | 1 | |a Natera Kindelán, Clara |e verfasserin |4 aut | |
| 700 | 1 | |a Boix-Palop, Lucía |e verfasserin |4 aut | |
| 700 | 1 | |a León Jiménez, Eva |e verfasserin |4 aut | |
| 700 | 1 | |a Galán-Sánchez, Fátima |e verfasserin |4 aut | |
| 700 | 1 | |a Del Arco Jiménez, Alfonso |e verfasserin |4 aut | |
| 700 | 1 | |a Bahamonde-Carrasco, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Vinuesa García, David |e verfasserin |4 aut | |
| 700 | 1 | |a Smithson Amat, Alejandro |e verfasserin |4 aut | |
| 700 | 1 | |a Cuquet Pedragosa, Jordi |e verfasserin |4 aut | |
| 700 | 1 | |a Reche Molina, Isabel María |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez Camacho, Inés |e verfasserin |4 aut | |
| 700 | 1 | |a Merino de Lucas, Esperanza |e verfasserin |4 aut | |
| 700 | 1 | |a Gutiérrez-Gutiérrez, Belén |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez Baño, Jesús |e verfasserin |4 aut | |
| 700 | 1 | |a López Cortés, Luis Eduardo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Antibiotics (Basel, Switzerland) |d 2012 |g 12(2023), 1 vom: 09. Jan. |w (DE-627)NLM243235135 |x 2079-6382 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2023 |g number:1 |g day:09 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/antibiotics12010129 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2023 |e 1 |b 09 |c 01 | ||